Jens Geginat

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Pro-inflammatory intestinal Th17-cells are tissue-resident, accumulate in the epithelia in Crohn's disease, and predict unresponsiveness to vedolizumab.

Pro-inflammatory intestinal Th17-cells are tissue-resident, accumulate in the epithelia in Crohn's disease, and predict unresponsiveness to vedolizumab.

Journal: Journal of Crohn's & colitis

Published: June 10, 2026

Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells.

Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells.

Journal: Science advances

Published: October 03, 2025

Autosomal Dominant Hyper-IgE Syndrome Patients Retain IL10-Producing preTh17-Cells That Are Activated by Opportunistic Pathogens and Support IgE Production.

Autosomal Dominant Hyper-IgE Syndrome Patients Retain IL10-Producing preTh17-Cells That Are Activated by Opportunistic Pathogens and Support IgE Production.

Journal: Allergy

Published: June 23, 2025

The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES+ Tr1-Like Cells.

The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMES+ Tr1-Like Cells.

Journal: European journal of immunology

Published: November 04, 2024

Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.

Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.

Journal: International journal of cancer

Published: July 03, 2024

Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs.

Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs.

Journal: American journal of respiratory cell and molecular biology

Published: February 01, 2024

Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study.

Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study.

Journal: The Lancet. Respiratory medicine

Published: December 21, 2023

Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue.

Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue.

Journal: Cell discovery

Published: December 17, 2023

Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.

Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.

Journal: European thyroid journal

Published: November 18, 2023

Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals.

Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals.

Journal: Clinical immunology (Orlando, Fla.)

Published: October 02, 2023

Characterization of human CD4+EOMES+GzmK+ T-cell subsets unveils an uncoupling of suppressive functions from IL-10-producing capacities.

Characterization of human CD4+EOMES+GzmK+ T-cell subsets unveils an uncoupling of suppressive functions from IL-10-producing capacities.

Journal: European journal of immunology

Published: July 19, 2023

An Intestinal Th17 Subset is Associated with Inflammation in Crohn's Disease and Activated by Adherent-invasive Escherichia coli.

An Intestinal Th17 Subset is Associated with Inflammation in Crohn's Disease and Activated by Adherent-invasive Escherichia coli.

Journal: Journal of Crohn's & colitis

Published: July 18, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026